Nephrology and Urology Incontinence Devices Market

Published Jun 28, 2022

Length 250 Pages

SKU # FMARI18055936

Description

Nephrology and Urology Incontinence Devices Market

Incontinence Devices are used in the treatment of urinary tract and nephrological disorders of patients such as Chronic Kidney Disease (CKD), Kidney Stone, Benign Prostatic Hyperplasia (BPH), End Stage Renal Disease (ESRD), urinary incontinence of pelvic organ prolapse.

According to WHO, more than 190 million patients are suffering from chronic renal failure and undergo renal dialysis and more than 220 million males suffer from diseases associated with prostate glands such as swelling that results in blockage of the flow of urine through the body. The United States national institute of Diabetes and Digestive and kidney diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S.

Nephrology and Urology Incontinence Devices Market: Drivers and Restraints

Presently, the global market for incontinence devices is primarily driven by the rising prevalence of Chronic Kidney Disease (CKD), Benign Prostatic Hyperplasia (BPH), and End Stage Renal Disease (ESRD) Also, increasing prevalence of diabetes and hypertension, the aging population and a shortage of kidney donors for transplant. Growing awareness programs bout this particular disease and personal hygiene among patients will lead the market in the forecast years.

Also, with the increase in healthcare expenditure and favorable reimbursement in developed countries, the market is expected to have healthy growth.

Nephrology and Urology Incontinence Devices Market: Segmentation

The nephrology and urology-incontinence devices global market is segmented into the following types:

Protective Garments for Incontinence
Adult Diapers
Absorbent Pads
Plastic Pants
Protective Undergarments
Urinary Catheters
Foley Catheters
Intermittent Catheters
External Catheters
Urine Bags
Leg Bags
Bedside Bags
Nephrology and Urology Incontinence Devices Market: Overview

With the rapid technological advancement in the healthcare industry, rising incidence of nephron and urological disorders, increasing prevalence of diabetes and hypertension, and aging population. The market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Nephrology and Urology Incontinence Devices Market: Region-wise Outlook

Depending on geographic regions, the incontinence devices global market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe are expected to capture the largest market shares followed by Asia Pacific countries where the market is expected to grow due to increasing awareness of personal hygiene, and an increase in disposable income of middle-class consumers.

Nephrology and Urology Incontinence Devices Market: Key Players

Some of the key participating players in the nephrology and urology-incontinence devices global market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimerly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology, and applications.

The report covers an exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, Australia & New Zealand)
Japan
Middle East and Africa (S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

1. Executive Summary: 1.1. Global Market Outlook; 1.2. Demand-side Trends; 1.3. Supply-side Trends; 1.4. Technology Roadmap Analysis; 1.5. Analysis and Recommendations
2. Market Overview: 2.1. Market Coverage / Taxonomy; 2.2. Market Definition / Scope / Limitations
3. Market Background: 3.1. Market Dynamics; 3.1.1. Drivers; 3.1.2. Restraints; 3.1.3. Opportunity; 3.1.4. Trends; 3.2. Scenario Forecast; 3.2.1. Demand in Optimistic Scenario; 3.2.2. Demand in Likely Scenario; 3.2.3. Demand in Conservative Scenario; 3.3. Opportunity Map Analysis; 3.4. Investment Feasibility Matrix; 3.5. PESTLE and Porter’s Analysis; 3.6. Regulatory Landscape; 3.6.1. By Key Regions; 3.6.2. By Key Countries; 3.7. Regional Parent Market Outlook
4. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast, 2022-2032: 4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021; 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032; 4.2.1. Y-o-Y Growth Trend Analysis; 4.2.2. Absolute $ Opportunity Analysis
5. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type: 5.1. Introduction / Key Findings; 5.2. Historical Market Size Value (US$ Bn) Analysis By Product Type, 2017-2021; 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product Type, 2022-2032; 5.3.1. Penile Compression Device; 5.3.2. Pessary; 5.3.3. Urethral Insert; 5.3.4. Artificial Urinary Sphincter; 5.3.5. Bladder Neck Support Device; 5.3.6. Urine Seal; 5.3.7. Absorbent Products; 5.3.8. Catheters; 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021; 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032; Deep-dive segmentation will be available in the sample on request
6. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Type: 6.1. Introduction / Key Findings; 6.2. Historical Market Size Value (US$ Bn) Analysis By Type, 2017-2021; 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Type, 2022-2032; 6.3.1. Stress Incontinence; 6.3.2. Urge incontinence; 6.3.3. Overflow Incontinence; 6.3.4. Functional Incontinence; 6.3.5. Mixed Incontinence; 6.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021; 6.5. Absolute $ Opportunity Analysis By Type, 2022-2032; Deep-dive segmentation will be available in the sample on request
7. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By End User: 7.1. Introduction / Key Findings; 7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021; 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032; 7.3.1. Hospitals; 7.3.2. Specialty Clinics; 7.3.3. Homecare Settings; 7.3.4. Nursing Homes; 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021; 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032; Deep-dive segmentation will be available in the sample on request
8. Global Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region: 8.1. Introduction; 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021; 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032; 8.3.1. North America; 8.3.2. Latin America; 8.3.3. Europe; 8.3.4. East Asia; 8.3.5. South Asia & Pacific; 8.3.6. MEA; 8.4. Market Attractiveness Analysis By Region
9. North America Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 9.2.1. By Country; 9.2.1.1. U.K.; 9.2.1.2. Canada; 9.2.2. By Product Type; 9.2.3. By Type; 9.2.4. By End User; 9.3. Market Attractiveness Analysis; 9.3.1. By Country; 9.3.2. By Product Type; 9.3.3. By Type; 9.3.4. By End User; 9.4. Key Takeaways
10. Latin America Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 10.2.1. By Country; 10.2.1.1. Brazil; 10.2.1.2. Mexico; 10.2.1.3. Rest of Latin America; 10.2.2. By Product Type; 10.2.3. By Type; 10.2.4. By End User; 10.3. Market Attractiveness Analysis; 10.3.1. By Country; 10.3.2. By Product Type; 10.3.3. By Type; 10.3.4. By End User; 10.4. Key Takeaways
11. Europe Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 11.2.1. By Country; 11.2.1.1. Germany; 11.2.1.2. U.K.; 11.2.1.3. France; 11.2.1.4. Spain; 11.2.1.5. Italy; 11.2.1.6. Rest of Europe; 11.2.2. By Product Type; 11.2.3. By Type; 11.2.4. By End User; 11.3. Market Attractiveness Analysis; 11.3.1. By Country; 11.3.2. By Product Type; 11.3.3. By Type; 11.3.4. By End User; 11.4. Key Takeaways
12. East Asia Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 12.2.1. By Country; 12.2.1.1. China; 12.2.1.2. Japan; 12.2.1.3. South Korea; 12.2.2. By Product Type; 12.2.3. By Type; 12.2.4. By End User; 12.3. Market Attractiveness Analysis; 12.3.1. By Country; 12.3.2. By Product Type; 12.3.3. By Type; 12.3.4. By End User; 12.4. Key Takeaways
13. South Asia & Pacific Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 13.2.1. By Country; 13.2.1.1. India; 13.2.1.2. Thailand; 13.2.1.3. Indonesia; 13.2.1.4. Malaysia; 13.2.1.5. Singapore; 13.2.1.6. Australia; 13.2.1.7. New Zealand; 13.2.1.8. Rest of South Asia & Pacific; 13.2.2. By Product Type; 13.2.3. By Type; 13.2.4. By End User; 13.3. Market Attractiveness Analysis; 13.3.1. By Country; 13.3.2. By Product Type; 13.3.3. By Type; 13.3.4. By End User; 13.4. Key Takeaways
14. MEA Nephrology and Urology Incontinence Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021; 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032; 14.2.1. By Country; 14.2.1.1. GCC Countries; 14.2.1.2. South Africa; 14.2.1.3. Israel; 14.2.1.4. Rest of MEA; 14.2.2. By Product Type; 14.2.3. By Type; 14.2.4. By End User; 14.3. Market Attractiveness Analysis; 14.3.1. By Country; 14.3.2. By Product Type; 14.3.3. By Type; 14.3.4. By End User; 14.4. Key Takeaways
15. Key Countries Nephrology and Urology Incontinence Devices Market Analysis: 15.1. U.K.; 15.1.1. Pricing Analysis; 15.1.2. Market Share Analysis, 2021; 15.1.2.1. By Product Type; 15.1.2.2. By Type; 15.1.2.3. By End User; 15.2. Canada; 15.2.1. Pricing Analysis; 15.2.2. Market Share Analysis, 2021; 15.2.2.1. By Product Type; 15.2.2.2. By Type; 15.2.2.3. By End User; 15.3. Brazil; 15.3.1. Pricing Analysis; 15.3.2. Market Share Analysis, 2021; 15.3.2.1. By Product Type; 15.3.2.2. By Type; 15.3.2.3. By End User; 15.4. Mexico; 15.4.1. Pricing Analysis; 15.4.2. Market Share Analysis, 2021; 15.4.2.1. By Product Type; 15.4.2.2. By Type; 15.4.2.3. By End User; 15.5. Germany; 15.5.1. Pricing Analysis; 15.5.2. Market Share Analysis, 2021; 15.5.2.1. By Product Type; 15.5.2.2. By Type; 15.5.2.3. By End User; 15.6. U.K.; 15.6.1. Pricing Analysis; 15.6.2. Market Share Analysis, 2021; 15.6.2.1. By Product Type; 15.6.2.2. By Type; 15.6.2.3. By End User; 15.7. France; 15.7.1. Pricing Analysis; 15.7.2. Market Share Analysis, 2021; 15.7.2.1. By Product Type; 15.7.2.2. By Type; 15.7.2.3. By End User; 15.8. Spain; 15.8.1. Pricing Analysis; 15.8.2. Market Share Analysis, 2021; 15.8.2.1. By Product Type; 15.8.2.2. By Type; 15.8.2.3. By End User; 15.9. Italy; 15.9.1. Pricing Analysis; 15.9.2. Market Share Analysis, 2021; 15.9.2.1. By Product Type; 15.9.2.2. By Type; 15.9.2.3. By End User; 15.10. China; 15.10.1. Pricing Analysis; 15.10.2. Market Share Analysis, 2021; 15.10.2.1. By Product Type; 15.10.2.2. By Type; 15.10.2.3. By End User; 15.11. Japan; 15.11.1. Pricing Analysis; 15.11.2. Market Share Analysis, 2021; 15.11.2.1. By Product Type; 15.11.2.2. By Type; 15.11.2.3. By End User; 15.12. South Korea; 15.12.1. Pricing Analysis; 15.12.2. Market Share Analysis, 2021; 15.12.2.1. By Product Type; 15.12.2.2. By Type; 15.12.2.3. By End User; 15.13. India; 15.13.1. Pricing Analysis; 15.13.2. Market Share Analysis, 2021; 15.13.2.1. By Product Type; 15.13.2.2. By Type; 15.13.2.3. By End User; 15.14. Thailand; 15.14.1. Pricing Analysis; 15.14.2. Market Share Analysis, 2021; 15.14.2.1. By Product Type; 15.14.2.2. By Type; 15.14.2.3. By End User; 15.15. Indonesia; 15.15.1. Pricing Analysis; 15.15.2. Market Share Analysis, 2021; 15.15.2.1. By Product Type; 15.15.2.2. By Type; 15.15.2.3. By End User; 15.16. Malaysia; 15.16.1. Pricing Analysis; 15.16.2. Market Share Analysis, 2021; 15.16.2.1. By Product Type; 15.16.2.2. By Type; 15.16.2.3. By End User; 15.17. Singapore; 15.17.1. Pricing Analysis; 15.17.2. Market Share Analysis, 2021; 15.17.2.1. By Product Type; 15.17.2.2. By Type; 15.17.2.3. By End User; 15.18. Australia; 15.18.1. Pricing Analysis; 15.18.2. Market Share Analysis, 2021; 15.18.2.1. By Product Type; 15.18.2.2. By Type; 15.18.2.3. By End User; 15.19. New Zealand; 15.19.1. Pricing Analysis; 15.19.2. Market Share Analysis, 2021; 15.19.2.1. By Product Type; 15.19.2.2. By Type; 15.19.2.3. By End User; 15.20. GCC Countries; 15.20.1. Pricing Analysis; 15.20.2. Market Share Analysis, 2021; 15.20.2.1. By Product Type; 15.20.2.2. By Type; 15.20.2.3. By End User; 15.21. South Africa; 15.21.1. Pricing Analysis; 15.21.2. Market Share Analysis, 2021; 15.21.2.1. By Product Type; 15.21.2.2. By Type; 15.21.2.3. By End User; 15.22. Israel; 15.22.1. Pricing Analysis; 15.22.2. Market Share Analysis, 2021; 15.22.2.1. By Product Type; 15.22.2.2. By Type; 15.22.2.3. By End User
16. Market Structure Analysis: 16.1. Competition Dashboard; 16.2. Competition Benchmarking; 16.3. Market Share Analysis of Top Players; 16.3.1. By Regional; 16.3.2. By Product Type; 16.3.3. By Type; 16.3.4. By End User
17. Competition Analysis: 17.1. Competition Deep Dive; 17.1.1. Becton, Dickinson and Company; 17.1.1.1. Overview; 17.1.1.2. Product Portfolio; 17.1.1.3. Profitability by Market Segments; 17.1.1.4. Sales Footprint; 17.1.1.5. Strategy Overview; 17.1.1.5.1. Marketing Strategy; 17.1.2. UROMED Kurt Drews KG; 17.1.2.1. Overview; 17.1.2.2. Product Portfolio; 17.1.2.3. Profitability by Market Segments; 17.1.2.4. Sales Footprint; 17.1.2.5. Strategy Overview; 17.1.2.5.1. Marketing Strategy; 17.1.3. Stryker Corporation; 17.1.3.1. Overview; 17.1.3.2. Product Portfolio; 17.1.3.3. Profitability by Market Segments; 17.1.3.4. Sales Footprint; 17.1.3.5. Strategy Overview; 17.1.3.5.1. Marketing Strategy; 17.1.4. B. Braun Melsungen AG; 17.1.4.1. Overview; 17.1.4.2. Product Portfolio; 17.1.4.3. Profitability by Market Segments; 17.1.4.4. Sales Footprint; 17.1.4.5. Strategy Overview; 17.1.4.5.1. Marketing Strategy; 17.1.5. Boston Scientific Corporation; 17.1.5.1. Overview; 17.1.5.2. Product Portfolio; 17.1.5.3. Profitability by Market Segments; 17.1.5.4. Sales Footprint; 17.1.5.5. Strategy Overview; 17.1.5.5.1. Marketing Strategy; 17.1.6. Cook Medical LLC; 17.1.6.1. Overview; 17.1.6.2. Product Portfolio; 17.1.6.3. Profitability by Market Segments; 17.1.6.4. Sales Footprint; 17.1.6.5. Strategy Overview; 17.1.6.5.1. Marketing Strategy; 17.1.7. CooperSurgical, Inc.; 17.1.7.1. Overview; 17.1.7.2. Product Portfolio; 17.1.7.3. Profitability by Market Segments; 17.1.7.4. Sales Footprint; 17.1.7.5. Strategy Overview; 17.1.7.5.1. Marketing Strategy; 17.1.8. Medgyn Products, Inc.; 17.1.8.1. Overview; 17.1.8.2. Product Portfolio; 17.1.8.3. Profitability by Market Segments; 17.1.8.4. Sales Footprint; 17.1.8.5. Strategy Overview; 17.1.8.5.1. Marketing Strategy; 17.1.9. Bioderm Inc.; 17.1.9.1. Overview; 17.1.9.2. Product Portfolio; 17.1.9.3. Profitability by Market Segments; 17.1.9.4. Sales Footprint; 17.1.9.5. Strategy Overview; 17.1.9.5.1. Marketing Strategy; 17.1.10. Thomas Medical, Inc.; 17.1.10.1. Overview; 17.1.10.2. Product Portfolio; 17.1.10.3. Profitability by Market Segments; 17.1.10.4. Sales Footprint; 17.1.10.5. Strategy Overview; 17.1.10.5.1. Marketing Strategy; 17.1.11. Essity Hygiene and Health AB; 17.1.11.1. Overview; 17.1.11.2. Product Portfolio; 17.1.11.3. Profitability by Market Segments; 17.1.11.4. Sales Footprint; 17.1.11.5. Strategy Overview; 17.1.11.5.1. Marketing Strategy; 17.1.12. ZEPHYR SURGICAL IMPLANTS SÀRL; 17.1.12.1. Overview; 17.1.12.2. Product Portfolio; 17.1.12.3. Profitability by Market Segments; 17.1.12.4. Sales Footprint; 17.1.12.5. Strategy Overview; 17.1.12.5.1. Marketing Strategy; 17.1.13. Coloplast Corp.; 17.1.13.1. Overview; 17.1.13.2. Product Portfolio; 17.1.13.3. Profitability by Market Segments; 17.1.13.4. Sales Footprint; 17.1.13.5. Strategy Overview; 17.1.13.5.1. Marketing Strategy; 17.1.14. Femeda Ltd.; 17.1.14.1. Overview; 17.1.14.2. Product Portfolio; 17.1.14.3. Profitability by Market Segments; 17.1.14.4. Sales Footprint; 17.1.14.5. Strategy Overview; 17.1.14.5.1. Marketing Strategy; 17.1.15. Domtar Corporation; 17.1.15.1. Overview; 17.1.15.2. Product Portfolio; 17.1.15.3. Profitability by Market Segments; 17.1.15.4. Sales Footprint; 17.1.15.5. Strategy Overview; 17.1.15.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Pricing

Currency Rates

Single User Email from Publisher $5,000
Site License Fulfilled by Publisher $7,500
Global Site License Email from Publisher $10,000

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now